CN103316263B - Medicine composition for treating membranous dysmenorrhea - Google Patents
Medicine composition for treating membranous dysmenorrhea Download PDFInfo
- Publication number
- CN103316263B CN103316263B CN201310274866.7A CN201310274866A CN103316263B CN 103316263 B CN103316263 B CN 103316263B CN 201310274866 A CN201310274866 A CN 201310274866A CN 103316263 B CN103316263 B CN 103316263B
- Authority
- CN
- China
- Prior art keywords
- parts
- herba
- radix
- grams
- fructus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicine composition for treating membranous dysmenorrheal. The medicine composition is prepared from the following substances: semen celosiae, radix scrophulariae, pterocephalus hookeri, herba polygoni perfoliati, common bombax flower, lophatherum gracile, thlaspi arvense, fructus arctii, liquorice, smilax, honeysuckle, herba gendarussae, American ginseng, rhizoma dioscoreae septemlobae, radix rehmanniae, caulis mahoniae, retinervus luffae fructus, herba asari, folium sauropi, scutellaria baicalensis, ricepaper pith, radix paeoniae rubra, herba siegesbeckiae, white hyacinth bean, Chinese angelica, folium sennae, lychee seed, concha arcae, herba agrimoniae, peucedanum decursivum, poria cocos, fructus broussonetiae, cassia twig, cicada slough, peach kernel, pinellia ternata, frankincense, kelp, herba cichorii, manchurian lilac bark, rhizoma nelumbinis and piper cubeba. The medicine composition for treating membranous dysmenorrheal provided by the invention has the characteristics of low cost, easiness in preparation, little toxic and side effects and obvious curative effect.
Description
Technical field
The present invention relates to drug world, specifically, relate to a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea.
Background technology
Film sample dysmenorrhea is the appellation of the special dysmenorrhea of a class, refer to that menstrual phase (generally at menstrual phase 2-3 days) lower abdomen has an intense pain, discharge the class primary dysmenorrhea that the rear pain of rotten meat sample of blood piece (being endometrium flaking) is alleviated gradually, also claim " de-membranous dysmenorrhea ".Mostly occur after menophania in 2-3, the state of an illness increased progressively gradually and increases the weight of with the age.This disease is different from general dysmenorrhea, loses Zhi Yanzhi, can bring out serious premenstrual tension syndrome, secondary organic dysmenorrhea, sterility and infertility etc.The at present same primary dysmenorrhea of western medical treatment method, uses PGSI menstrual period, or oral contraceptive etc. at ordinary times, and it is satisfied that curative effect is owed, and easily recurrence can not improve reproductive function.
Summary of the invention
The object of this invention is to provide a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea.
In order to realize object of the present invention, the invention provides a kind of pharmaceutical composition for the treatment of film sample dysmenorrhea, it is made up of the material of following weight proportioning: 23 parts of Semen Celosiae, 25 parts of Radix Scrophulariaes, 33 parts of Herba pterocephali, 35 parts of Herba Polygoni cymosis, 34 parts of Flos Bombacis Malabaricis, 32 parts of Herba Lophatheris, 26 parts of Herba Thlaspiss, 18 parts of Fructus Arctiis, 24 parts, Radix Glycyrrhizae, 25 parts of Rhizoma Smilacis Chinensiss, 36 parts of Flos Loniceraes, 23 parts of Herba Gendarussaes, 21 parts of Radix Panacis Quinquefoliis, 24 parts of Rhizoma Dioscoreae Septemlobaes, 28 parts, the Radix Rehmanniae, 33 parts of Caulis Mahoniaes, 23 parts of Retinervus Luffae Fructuss, 36 parts of Herba Asaris, 36 parts of Folium Sauropis, 30 parts of Radix Scutellariaes, 37 parts of Medulla Stachyuri (Medulla Helwingiae)s, 28 parts of Radix Paeoniae Rubra, 26 parts of Herba Siegesbeckiaes, 37 parts of Semen Lablab Albums, 29 parts of Radix Angelicae Sinensis, 33 parts of Folium Sennae, 27 parts of Semen Litchis, 25 parts of Concha Arcaes, 34 parts of Herba Agrimoniaes, 23 parts of RADIX PEUCEDANI, 27 parts, Poria, 25 parts of Fructus Broussonetiaes, 21 parts of Ramulus Cinnamomi, 20 parts of Periostracum Cicadaes, 28 parts, Semen Persicae, 23 parts of the Rhizoma Pinelliaes, 25 parts of Olibanums, 27 parts of Thallus Laminariae (Thallus Eckloniae)s, 37 parts of Herba Cichoriis, 35 parts of Cortex Syingae Amurensiss, 35 parts of 33 parts of Nodus Nelumbinis Rhizomatis and Fructus Litseae.
Preferably, described pharmaceutical composition can be tablet, dispersible tablet, powder or decoction.
The pharmaceutical composition for the treatment of film sample dysmenorrhea of the present invention has the advantages that cost is low, preparation is easy, toxic and side effects is little, curative effect is showing.
Detailed description of the invention
Embodiment 1:
Take 23 grams of Semen Celosiae, 25 grams of Radix Scrophulariaes, 33 grams of Herba pterocephali, 35 grams of Herba Polygoni cymosis, 34 grams of Flos Bombacis Malabaricis, 32 grams of Herba Lophatheris, 26 grams of Herba Thlaspiss, 18 grams of Fructus Arctiis, 24 grams, Radix Glycyrrhizae, 25 grams of Rhizoma Smilacis Chinensiss, 36 grams of Flos Loniceraes, 23 grams of Herba Gendarussaes, 21 grams of Radix Panacis Quinquefoliis, 24 grams of Rhizoma Dioscoreae Septemlobaes, 28 grams, the Radix Rehmanniae, 33 grams of Caulis Mahoniaes, 23 grams of Retinervus Luffae Fructuss, 36 grams of Herba Asaris, 36 grams of Folium Sauropis, 30 grams of Radix Scutellariaes, 37 grams of Medulla Stachyuri (Medulla Helwingiae)s, 28 grams of Radix Paeoniae Rubra, 26 grams of Herba Siegesbeckiaes, 37 grams of Semen Lablab Albums, 29 grams of Radix Angelicae Sinensis, 33 grams of Folium Sennae, 27 grams of Semen Litchis, 25 grams of Concha Arcaes, 34 grams of Herba Agrimoniaes, 23 grams of RADIX PEUCEDANI, 27 grams, Poria, 25 grams of Fructus Broussonetiaes, 21 grams of Ramulus Cinnamomi, 20 grams of Periostracum Cicadaes, 28 grams, Semen Persicae, 23 grams of the Rhizoma Pinelliaes, 25 grams of Olibanums, 27 grams of Thallus Laminariae (Thallus Eckloniae)s, 37 grams of Herba Cichoriis, 35 grams of Cortex Syingae Amurensiss, 35 grams of 33 grams of Nodus Nelumbinis Rhizomatis and Fructus Litseae, add 8000 ml waters, at 80 DEG C, heat 5 hours, filter.Filtrate is concentrated into 800 milliliters, obtains decoction of the present invention.
Experimental example
1.1 diagnostic criteria
Western medicine diagnose canonical reference " obstetrics and gynecology " (Feng Youji, Shen clang. obstetrics and gynecology, Beijing: People's Health Publisher, 2010:249) work out: (1) has periodicity lower abdomen in menstrual period pendant pain, endometrium comes off in a tubular form, and continuous 3 menstrual cycle can not spontaneous remission; (2) gynecologial examination and ultrasound diagnosis prompting uterus adnexa no abnormality seen; (3) examination of basal body temperature confirms that dysmenorrhea occurs in ovulatory cycle.Tcm diagnosis canonical reference " Gynecology of Chinese Medicine " (Zhang Yuzhen. Gynecology of Chinese Medicine. Beijing: China Traditional Chinese Medicine Publishing House, 2007:61) dialectical main points: abdominal pain during menstruation, within 2-3 days, pain is acute, and purplish red have a large amount of clots, discharge rotten meat sample of blood piece at every turn after pain can extenuate, companion's aversion to cold and cold limbs, the stool pool is thin, or sterility, or habitual abortion, purplish tongue gas thin fur or thin greasy, deep and stringy pulse etc.
1.2 inclusive criteria
(1) meet the diagnostic criteria of film sample dysmenorrhea; (2) age is between 16-36 year; (3) more than course of disease March.
Choose female patient 60 examples that meet above-mentioned standard, unmarried 37 examples, married 23 examples; Year mean age (23.0 ± 4.7); Individual month of average course of disease (24.0 ± 3.9).
With in embodiment 1 preparation decoction treat.Each oral 50 milliliters, respectively take 1 time every day sooner or later, treats continuously 1 month.
Efficacy determination method
With reference to " traditional Chinese medical science disease Standardization of diagnosis and curative effect " (State Administration of Traditional Chinese Medicine. traditional Chinese medical science disease Standardization of diagnosis and curative effect. Nanjing: the .1994.61 of publishing house of Nanjing University) in dysmenorrhea curative effect determinate standard formulate.Clinical cure: after taking medicine, stomachache and rotten meat sample of blood piece disappear, and 3 menstrual cycle of drug withdrawal do not recur, pain degree recovers " 0 " point person; Effective: pain obviously alleviates, rotten meat sample of blood piece disappears or alleviates, and disobedience analgesic can be adhered to work, and pain degree is that treatment integration is reduced to front below 1/2 of integration for the treatment of; Effective: suffer from abdominal pain and alleviate, rotten meat sample of blood piece reduces, take analgesic and can adhere to work, pain degree is that after treatment, integration is reduced to front below 1/3 of integration for the treatment of; Invalid: stomachache and rotten meat sample of blood piece are without changer.
Through treatment, after 60 routine patients take medicine, stomachache and rotten meat sample of blood piece disappear, and 3 menstrual cycle of drug withdrawal do not recur, and pain degree recovers " 0 " point, therefore all meet the standard of clinical cure.
Claims (1)
1. treat the pharmaceutical composition of film sample dysmenorrhea for one kind, it is characterized in that it is made up of the material of following weight proportioning: 23 parts of Semen Celosiae, 25 parts of Radix Scrophulariaes, 33 parts of Herba pterocephali, 35 parts of Herba Polygoni cymosis, 34 parts of Flos Bombacis Malabaricis, 32 parts of Herba Lophatheris, 26 parts of Herba Thlaspiss, 18 parts of Fructus Arctiis, 24 parts, Radix Glycyrrhizae, 25 parts of Rhizoma Smilacis Chinensiss, 36 parts of Flos Loniceraes, 23 parts of Herba Gendarussaes, 21 parts of Radix Panacis Quinquefoliis, 24 parts of Rhizoma Dioscoreae Septemlobaes, 28 parts, the Radix Rehmanniae, 33 parts of Caulis Mahoniaes, 23 parts of Retinervus Luffae Fructuss, 36 parts of Herba Asaris, 36 parts of Folium Sauropis, 30 parts of Radix Scutellariaes, 37 parts of Medulla Stachyuri (Medulla Helwingiae)s, 28 parts of Radix Paeoniae Rubra, 26 parts of Herba Siegesbeckiaes, 37 parts of Semen Lablab Albums, 29 parts of Radix Angelicae Sinensis, 33 parts of Folium Sennae, 27 parts of Semen Litchis, 25 parts of Concha Arcaes, 34 parts of Herba Agrimoniaes, 23 parts of RADIX PEUCEDANI, 27 parts, Poria, 25 parts of Fructus Broussonetiaes, 21 parts of Ramulus Cinnamomi, 20 parts of Periostracum Cicadaes, 28 parts, Semen Persicae, 23 parts of the Rhizoma Pinelliaes, 25 parts of Olibanums, 27 parts of Thallus Laminariae (Thallus Eckloniae)s, 37 parts of Herba Cichoriis, 35 parts of Cortex Syingae Amurensiss, 35 parts of 33 parts of Nodus Nelumbinis Rhizomatis and Fructus Litseae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310274866.7A CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201310274866.7A CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN103316263A CN103316263A (en) | 2013-09-25 |
| CN103316263B true CN103316263B (en) | 2014-07-30 |
Family
ID=49185496
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201310274866.7A Expired - Fee Related CN103316263B (en) | 2013-07-03 | 2013-07-03 | Medicine composition for treating membranous dysmenorrhea |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103316263B (en) |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101095930A (en) * | 2007-07-12 | 2008-01-02 | 张琴 | Olibanum zedoary plaster for treating menorrhalgia and the preparation technics thereof |
| CN101129902B (en) * | 2007-08-31 | 2010-07-21 | 南京中医药大学 | Application of disease-eliminating drink in preparing medicine for treating menorrhalgia and uterine gland myopathia |
| CN101264314A (en) * | 2008-05-04 | 2008-09-17 | 北京中科仁和科技有限公司 | Medicaments assembly for clearing heat and detoxication, activating blood circulation and removing stasis, and diminishing inflammation and reducing pain |
-
2013
- 2013-07-03 CN CN201310274866.7A patent/CN103316263B/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| CN103316263A (en) | 2013-09-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102370725B (en) | A kind of compound Chinese medicinal preparation treating chronic pelvic inflammatory disease and preparation method thereof | |
| CN102488879B (en) | Medicinal composition for treating rheumatism | |
| CN103919940A (en) | Chinese medicinal composition for treating hemorrhoid | |
| CN102008584B (en) | Drug for treating cold-aggregating qi-stasis dysmenorrhea | |
| CN102284050B (en) | Chinese medicine composition for treating infertility caused by cold uterus | |
| CN103800843A (en) | Traditional Chinese medicine composition for treating chronic pelvic inflammation | |
| CN103585591A (en) | Traditional Chinese medicine for treating gallstones | |
| CN104435519A (en) | Pharmaceutical composition for treating primary dysmenorrhea | |
| CN105194584A (en) | Medicine for treating dysmenorrhea | |
| CN102091296B (en) | Medicament for treating breast hyperplasia | |
| CN103860882A (en) | Medicinal preparation for treating chronic cervicitis | |
| CN103316263B (en) | Medicine composition for treating membranous dysmenorrhea | |
| CN104013704B (en) | Pharmaceutical composition for treating chronic pelvic inflammatory disease and preparation method of composition | |
| CN103463582A (en) | Medicinal composition for treating pelvic inflammation, as well as preparation and application thereof | |
| CN107753880A (en) | A kind of pharmaceutical composition for treating dysmenorrhoea and preparation method thereof | |
| CN102743686B (en) | The scorching clearing capsule of a kind of basin | |
| CN103690614A (en) | Traditional Chinese medicine for treating prostatitis | |
| CN103330897B (en) | Pharmaceutical composition for treating renal and ureteral calculus | |
| CN102698065B (en) | Medicine composition for treating primary dysmenorrhea | |
| CN104162043A (en) | Traditional Chinese medicine used for treatment of allergic nodular cutaneous vasculitis | |
| CN103301368A (en) | Medicament for treating hyperactivity | |
| CN103830646B (en) | A kind of preparation method of the pharmaceutical composition treating kidney or ureter stone | |
| CN103977214A (en) | External preparation for treating chronic pelvic inflammatory disease | |
| CN104491717A (en) | Medicament for treating mammary hyperplasia | |
| CN104547964A (en) | Traditional Chinese medicine composition and preparation for treating chronic pelvic inflammatory disease |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| ASS | Succession or assignment of patent right |
Owner name: LI YANNAN Free format text: FORMER OWNER: LI HUA Effective date: 20140702 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| C53 | Correction of patent for invention or patent application | ||
| CB03 | Change of inventor or designer information |
Inventor after: Li Yannan Inventor before: Li Hua |
|
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 100083 HAIDIAN, BEIJING TO: 272000 JINING, SHANDONG PROVINCE Free format text: CORRECT: INVENTOR; FROM: LI HUA TO: LI YANNAN |
|
| TA01 | Transfer of patent application right |
Effective date of registration: 20140702 Address after: Chinese Medicine Hospital No. 3 Jining City Road 272000 in Shandong Province, Jining City Applicant after: Li Yannan Address before: Building 100083 Beijing city Haidian District Yihai Qinghua East Road, Room 608 Applicant before: Li Hua |
|
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20140730 Termination date: 20150703 |
|
| EXPY | Termination of patent right or utility model |